Date Title Description PDF
12 Apr 2021 On business and financial situation The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. Download
02 Mar 2021 On business and financial situation The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
02 Mar 2021 On business and financial situation The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
24 Feb 2021 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download

Pages

Date Title Description PDF
13 May 2021 On business and financial situation The company releases the press release related to first quarter 2021 financial results Download
13 May 2021 On business and financial situation ROVI releases the first quarter 2021 results presentation Download
06 Apr 2021 Liquidity contracts and specialists Liquidity contract: transactions conducted in the first quarter of 2021 Download
24 Feb 2021 On business and financial situation The company releases the press release related to 2020 financial results Download
24 Feb 2021 On business and financial situation ROVI releases the 2020 Results presentation Download

Pages

Date Title Description PDF
09 Oct 2015 Otros sobre operaciones corporativas Download
08 Oct 2015 Otros sobre operaciones corporativas Download
30 Jul 2015 Información sobre resultados (2) Download
30 Jul 2015 Información sobre resultados Download
30 Jun 2015 Información sobre dividendos Download

Pages